The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it.

1. Patient experience and burden of haemolytic disease of the foetus and newborn: a systematic review.BMC pregnancy and childbirth · 2025
   Pooled it
2. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.The Cochrane database of systematic reviews · 2015
   Pooled it
3. Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.Blood transfusion = Trasfusione del sangue · 2015
   Guideline
4. Prevalence of alloantibodies among antenatal women attending a teaching hospital in central Kerala.Journal of family medicine and primary care · 2025
   Article
5. Noninvasive fetal blood group antigen genotyping.Blood transfusion = Trasfusione del sangue · 2025
   Review
6. Maternal red blood cell alloimmunization prevalence in the United States.Blood advances · 2024
   Article
7. Red Blood Cell Alloimmunization in Pregnancy: A Review of the Pathophysiology, Prevalence, and Risk Factors.Cureus · 2024
   Review
8. Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations.Vox sanguinis · 2022
   Review
9. Upregulation of miR-181a-5p and miR-125b-2-3p in the Maternal Circulation of Fetuses with Rh-Negative Hemolytic Disease of the Fetus and Newborn Could Be Related to Dysfunction of Placental Function.Disease markers · 2022
   Article
10. Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis.Maternal health, neonatology and perinatology · 2021
    Review
11. Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions.Canadian family physician Medecin de famille canadien · 2020
    Review
12. Bilirubin Induced Encephalopathy.Iranian journal of child neurology · 2020
    Review
13. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.PloS one · 2020
    Article
14. Fetal Rhesus D Genotyping and Sex Determination from Maternal Plasma of Rhesus D-Negative Antenatal Population: The Usefulness of Conventional Polymerase Chain Reaction in Resource-limited Settings.Obstetrics and gynecology international · 2020
    Article
15. Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan.Journal of blood medicine · 2019
    Article
16. Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2018
    Article
17. Outcomes of subsequent pregnancy following obstetric transfusion in a first birth.PloS one · 2018
    Article
18. Adoption of the American Academy of Pediatrics' neonatal hyperbilirubinemia guidelines and its effect on blood exchange transfusion rate in a tertiary care center in Amman, Jordan.Journal of blood medicine · 2018
    Article
19. Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2016
    Article
20. Red Cell Alloimmunization to Rhesus Antigen Among Pregnant Women Attending a Tertiary Care Hospital in Oman.Oman medical journal · 2016
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

8 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as